Discover
FHTX
Foghorn Therapeutics Inc.
4.14
2 x 3.55
2 x 6.10
bid
ask
-
0.06
1.43%
2 @ 07:30 PM
4.14 +0.00 (0.00%)
| Ytd | -23.33% | |
| 1y | -19.46% |
4.07
day range
4.25
3.53
52 week range
7.07
| Open | 4.21 | Prev Close | 4.20 | Low | 4.07 | High | 4.25 | Mkt Cap | 245.86M |
| Vol | 502.03K | Avg Vol | 349.94K | EPS | -0.99 | P/E | N/A | Forward P/E | -3.12 |
| Beta | 3.15 | Short Ratio | 7.62 | Inst. Own | 72.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 5.51 | 200-d Avg | 5.09 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 16.07M | ||
| Revenues (USD) | 16.07M | ||
| Gross Profit | 16.07M | ||
| Operating Expenses | 24.88M | ||
| Research and Development Expense | 18.52M | ||
| Selling, General and Administrative Expense | 6.35M | ||
| Operating Income | -8.80M | ||
| Net Income | -7.19M | ||
| Net Income Common Stock | -7.19M | ||
| Net Income Common Stock (USD) | -7.19M | ||
| Consolidated Income | -7.19M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -7.19M | ||
| Earning Before Interest & Taxes (USD) | -7.19M | ||
| Weighted Average Shares | 70.63M | ||
| Weighted Average Shares Diluted | 70.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 70.08M | ||
| Cash and Equivalents (USD) | 70.08M | ||
| Investments | 99.50M | ||
| Investments Current | 99.50M | ||
| Current Assets | 170.05M | ||
| Property, Plant & Equipment Net | 31.34M | ||
| Total Assets | 203.39M | ||
| Debt Current | 2.82M | ||
| Total Debt | 43.10M | ||
| Current Liabilities | 50.58M | ||
| Debt Non-Current | 40.28M | ||
| Total Liabilities | 284.43M | ||
| Accumulated Retained Earnings (Deficit) | -659.53M | ||
| Accumulated Other Comprehensive Income | -134.00K | ||
| Shareholders Equity | -81.04M | ||
| Shareholders Equity (USD) | -81.04M | ||
| Assets Non-Current | 33.35M | ||
| Total Debt (USD) | 43.10M | ||
| Deferred Revenue | 229.82M | ||
| Liabilities Non-Current | 233.86M | ||
| Trade and Non-Trade Payables | 3.21M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 771.00K | ||
| Net Cash Flow from Financing | -22.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.83M | ||
| Capital Expenditure | -50.00K | ||
| Issuance (Purchase) of Equity Shares | -22.00K | ||
| Net Cash Flow from Investing | -2.97M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.92M | ||
| Net Cash Flow from Operations | -17.84M | ||
| Share Based Compensation | 2.55M | ||